Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 47
2012 50
2013 70
2014 96
2015 110
2016 135
2017 142
2018 128
2019 102
2020 126
2021 203
2022 173
2023 193
2024 66

Text availability

Article attribute

Article type

Publication date

Search Results

1,641 results

Results by year

Filters applied: . Clear all
Page 1
Extramedullary disease in multiple myeloma.
Bansal R, Rakshit S, Kumar S. Bansal R, et al. Blood Cancer J. 2021 Sep 29;11(9):161. doi: 10.1038/s41408-021-00527-y. Blood Cancer J. 2021. PMID: 34588423 Free PMC article. Review.
Cutaneous manifestations of monoclonal gammopathy.
Claveau JS, Wetter DA, Kumar S. Claveau JS, et al. Blood Cancer J. 2022 Apr 11;12(4):58. doi: 10.1038/s41408-022-00661-1. Blood Cancer J. 2022. PMID: 35411042 Free PMC article. Review.
Extramedullary disease in multiple myeloma: a systematic literature review.
Bladé J, Beksac M, Caers J, Jurczyszyn A, von Lilienfeld-Toal M, Moreau P, Rasche L, Rosiñol L, Usmani SZ, Zamagni E, Richardson P. Bladé J, et al. Blood Cancer J. 2022 Mar 21;12(3):45. doi: 10.1038/s41408-022-00643-3. Blood Cancer J. 2022. PMID: 35314675 Free PMC article. Review.
Smoldering multiple myeloma current treatment algorithms.
Rajkumar SV, Kumar S, Lonial S, Mateos MV. Rajkumar SV, et al. Blood Cancer J. 2022 Sep 5;12(9):129. doi: 10.1038/s41408-022-00719-0. Blood Cancer J. 2022. PMID: 36064707 Free PMC article. Review.
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
Martin T, Dimopoulos MA, Mikhael J, Yong K, Capra M, Facon T, Hajek R, Špička I, Baker R, Kim K, Martinez G, Min CK, Pour L, Leleu X, Oriol A, Koh Y, Suzuki K, Casca F, Macé S, Risse ML, Moreau P. Martin T, et al. Blood Cancer J. 2023 May 9;13(1):72. doi: 10.1038/s41408-023-00797-8. Blood Cancer J. 2023. PMID: 37156782 Free PMC article. Clinical Trial.
1,641 results